Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Perspectives on Patient Support Programs

Posted by Matt Breese on Jul 25, 2017

Regulatory changes in the healthcare industry and consumer preferences are putting more pressure on pharmaceutical companies to show the value of their products. According to Guaurav N. Brahmbhatt, Head of Pharma Business at Health Care at Home India, pharma companies can increase their value offerings by creating patient support programs that are "innovative, complementary, collaborative, and patient-centric." 

Similar to your brand’s contracting strategy, patient assistance programs can have an enormous impact on the time-to-treatment for prescribers and patients. Your ability to establish a patient assistance program strategy, especially when there are barriers to prescribing, and deploy predictive analysis around how this program will impact revenue is essential.

Read More

Topics: Market Access, Branding & Marketing

Trends That Matter for Monitoring Chronic Conditions

Posted by Matt Breese on Jul 20, 2017

In our weekly Trends that Matter series, we provide engaging infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is how apps can help individuals with chronic diseases monitor their symptoms.

About half of all adults have one or more chronic health conditions, according to the Centers for Disease Control and Prevention (CDC). Mobile applications can help individuals with chronic diseases monitor their overall health, track their diet, record sleep habits, communicate with clinicians, and remember to take medications on schedule. 

Read More

Topics: Industry Trends

MMIT Reality Check on Growth Hormones (Jul 2017)

Posted by Matt Breese on Jul 18, 2017

According to our recent payer coverage analysis for HGH treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Market Access, Data & Analytics, Branding & Marketing

Perspectives on Optimizing Your "Superfans"

Posted by Matt Breese on Jul 18, 2017

When it comes to your brand’s digital footprint, being able to leverage your biggest supporting patients, prescribers and other advocates can drastically help you to amplify your message and establish more brand loyalty. As a pharma company, your treatment delivers tremendous value to patients.  Specifically, in rare disease areas such as hemophilia, patients often develop a strong brand loyalty.

In such a highly regulated industry, maintaining a human connection can separate you from the competition and improve your market share trajectory over time. 

Read More

Topics: Market Access, Branding & Marketing

MMIT Reality Check on Diabetes (Jul 2017)

Posted by Matt Breese on Jul 17, 2017

According to our recent payer coverage analysis for type 2 diabetes treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Trends That Matter for Digital Health

Posted by Matt Breese on Jul 13, 2017

In our weekly Trends that Matter series, we provide engaging infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is digital health. As digital technology continues to evolve, pharma companies must change their communication tactics to engage with patient communities. 

In the past, many pharma companies have shied away from digital marketing due to concerns over healthcare regulations. However, in the past year, the FDA’s Center for Devices and Radiological Health (CDRH) has expressed interest in advancing digital health initiatives. The FDA states:

Read More

Topics: Industry Trends

Perspectives on Crowded Disease Areas

Posted by Matt Breese on Jul 11, 2017

The pharma industry is becoming more competitive today because many companies are pursuing the same disease areas. Branding and marketing a drug in a crowded disease treatment landscape is a challenging task.

Defining a brand strategy that accounts for multiple direct competitors and adjusts promotional efforts based on a complex market access landscape helps overcome a crowded landscape.  

Read More

Topics: Market Access, Branding & Marketing

Trends That Matter for Supply Chain Innovation

Posted by Matt Breese on Jul 6, 2017

In our weekly Trends that Matter series, we provide engaging infographics and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is innovation in the pharmaceutical supply chain.

In recent years, the pharma industry has become more customer-centric. In order to improve customer experience, it is essential for supply chain executives to listen to feedback from the end users of their products. For example, according to the Pharmaceutical Executive:

Read More

Topics: Industry Trends

Trends That Matter for Wearables

Posted by Matt Breese on Jun 29, 2017

In our weekly Trends that Matter series, we provide engaging infographics and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is wearable devices. Today, medical technology is giving individuals greater control over their health.

Developments in the area of bio-sensing technology are improving the capabilities of wearables. According to Dr. Sima Ajami who conducts research on health information technology:

Read More

Topics: Industry Trends

MMIT Reality Check on Multiple Sclerosis (Jun 2017)

Posted by Matt Breese on Jun 29, 2017

According to our recent payer coverage analysis for multiple sclerosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing